Alzheimer’s Early Intervention Inflammatory Biomarker (AEIIB) Panel™
Alzheimer's Disease (inflammatory/autoimmune component)
DevelopmentActive
Key Facts
Indication
Alzheimer's Disease (inflammatory/autoimmune component)
Phase
Development
Status
Active
Company
About Moleculera Biosciences
Moleculera Biosciences is a commercial-stage precision medicine diagnostics company founded in 2012 and headquartered in Oklahoma City. The company's core offering is the Autoimmune Brain Panel™, a series of blood tests that helps clinicians diagnose immune-mediated neuropsychiatric disorders. Moleculera is leveraging its integrated technology platform—comprising diagnostic panels, a curated biorepository, and a biomarker discovery program—to expand into cardiovascular and Alzheimer's disease markets, addressing significant unmet needs in chronic, treatment-resistant conditions.
View full company profile